38 Result(s)
within
Choung-Soo Kim
Oncology
-
Article
Impact of preoperative chemotherapy on pathologic nodal status in muscle-invasive bladder cancer: optimal lymphadenectomy in the preoperative chemotherapy era
To investigate the impact of preoperative chemotherapy (pCTX) on pathologic nodal (pN) status and evaluate the optimal lymphadenectomy method according to clinical nodal (cN) status in patients with muscle-inv...
-
Article
Biopsy-detected Gleason grade 5 tumor is an additional prognostic factor in metastatic hormone-sensitive prostate cancer
A Gleason score ≥ 8, metastatic tumor burden, and visceral metastasis are known prognostic factors for patients with metastatic hormone-sensitive prostate cancer (mHSPC). Notably, however, these indicators hav...
-
Chapter
Surgical Treatment in Urinary Bladder Cancer
There are multiple treatment options in the surgical management of bladder cancer. It is important to know the histological diagnosis, cancer staging, and other prognostic factors (cancer grade, multifocality,...
-
Article
Open AccessPhase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR)
To evaluate the clinical outcomes of combination of androgen deprivation therapy (ADT), whole pelvic radiotherapy (WPRT), and stereotactic body radiotherapy (SBRT) boost in high-risk prostate cancer patients.
-
Article
Percent tumor volume vs American Joint Committee on Cancer staging system subclassification for predicting biochemical recurrence in patients with pathologic T2 prostate cancer
Here, we re-checked the American Joint Committee on Cancer 7th edition subclassification and confirmed the possibility of percent tumor volume as a prognostic factor for biochemical recurrence in the 8th editi...
-
Article
Open AccessCorrection to: The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway
In the original publication of this article [1], there are mistakes in Fig. 4d. The corrected Fig. 4 should be:
-
Article
Time to biochemical relapse after radical prostatectomy and efficacy of salvage radiotherapy in patients with prostate cancer
To investigate the prognostic and therapeutic implications of time to biochemical relapse (BCR) in patients with prostate cancer after radical prostatectomy.
-
Article
Open AccessThe small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway
Androgen receptor (AR)-targeted treatments improve the survival of castration-resistant prostate cancer (CRPC) patients; however, secondary resistance to these agents ultimately occurs in virtually all patient...
-
Article
Correction to: A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL
The blots of control and docetaxel for caspase-9, caspase-3, caspase-8, Bcl-XL, and tubulin in the Figure 4f were reused from Figure 4 of our previous paper published in Journal of Urology in 2010 ( ...
-
Article
Prognosis of carcinoma in situ according to the presence of papillary bladder tumors after bacillus Calmette–Guérin immunotherapy
This study aimed at determining the relationship between classification according to the papillary tumor pattern of carcinoma in situ (CIS) of the bladder and prognosis, as this has not yet been well established.
-
Article
Oncological effect of palliative transurethral resection of the prostate in patients with advanced prostate cancer: a propensity score matching study
We investigated the oncologic effect of palliative transurethral resection of the prostate (pTURP) in patients with prostate cancer who received primary androgen deprivation therapy.
-
Article
Combination treatment with docetaxel and histone deacetylase inhibitors downregulates androgen receptor signaling in castration-resistant prostate cancer
Backgrounds Since most patients with castration-resistant prostate cancer (CRPC) develop resistance to its standard therapy docetaxel, many studies have attempted to identify novel combination tr...
-
Article
Open AccessAndrogen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study
Here we assessed the influence of androgen deprivation therapy (ADT) during and/or after post-prostatectomy radiotherapy (RT) on biochemical recurrence (BCR) and radiographic progression in patients with prost...
-
Chapter
Neoadjuvant Therapy Prior to Radical Prostatectomy
The terminology “neoadjuvant” stemmed from Greek “neos” that means new or before and the Latin language “adjuvāre” that means help or aid. Neoadjuvant therapy is the application of systemic care before operati...
-
Article
Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma
We compared the oncological outcomes of papillary renal cell carcinoma (pRCC) with clear cell renal cell carcinoma (ccRCC) after partial nephrectomy (PN) in patients with pathologic T1a RCC.
-
Article
Does lymph node dissection during nephroureterectomy affect oncological outcomes in upper tract urothelial carcinoma patients without suspicious lymph node metastasis on preoperative imaging studies?
This study aimed to investigate the effects of lymph node dissection (LND) on upper tract urothelial carcinoma (UTUC) without suspicious lymph node (LN) metastasis on preoperative imaging studies.
-
Article
Impact of metastasectomy on prognosis in patients treated with targeted therapy for metastatic renal cell carcinoma
We evaluated the value of metastasectomy in patients treated with targeted therapy for metastatic renal cell carcinoma (mRCC).
-
Article
Oncological outcomes of patients with incidental pathological T3a stage small renal cell carcinoma after partial nephrectomy
This study was designed to evaluate and compare the oncological outcomes of patients with pathological T1a (pT1a) small renal cell carcinomas (RCCs) with those with incidental pathological T3a (pT3a) RCCs who ...
-
Article
Prognostic significance of platelet-derived growth factor receptor-β expression in localized clear cell renal cell carcinoma
We investigated the expression status of vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF)-B and their receptors in organ-confined clear cell renal cell carcinoma (ccRCC) to eval...
-
Article
Prognostic value of ABO blood group in patients with renal cell carcinoma: single-institution results from a large cohort
To evaluate the association between ABO blood group and prognosis in patients with renal cell carcinoma (RCC) undergoing surgery.
